CURADEL PHARMA

Live / Applied — First extension granted (statement of use) (as of 27 Mar 2026)

What this means for you

Not registered yet, but its 25 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98666457
Mark type
Stylized text
Filed
25 Jul 2024
Published for opposition
25 Feb 2025
Attorney of record
Gregory N. Brescia

Goods and services

  • Class 005 — Pharmaceuticals: Contrast agents for use in surgical and medical imaging and visualization; fluorescent contrast agents for use in surgical and medical imaging and visualization; exogenous contrast agents for use in surgical and medical imaging and visualization; near infrared contrast agents for use in surgical and medical imaging and visualization; exogenous near-infrared contrast agents for use in surgical and medical imaging and visualization; near-infrared contrast agents for use in surgical procedures; exogenous near-infrared contrast agents for use in surgical procedures; near-infrared contrast agents for use in medical imaging and visualization; exogenous near-infrared contrast agents for use in medical imaging and visualization; near-infrared contrast agents for use in real-time surgical imaging and visualization; exogenous near-infrared contrast agents for use in real-time surgical imaging and visualization; none of the foregoing being ophthalmic preparations, otorhinolaryngological preparations, or preparations for the treatment of inflammation; none of the foregoing are for use in connection with wound management, medical dressing materials, haemostats, sealants, and blood clotting agents

Owner

Prior registrations

Prosecution history

  • 28 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 27 Mar 2026 — SOU EXTENSION 1 GRANTED
  • 21 Oct 2025 — SOU EXTENSION 1 FILED
  • 25 Mar 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
  • 25 Mar 2026 — NOTICE OF REVIVAL - E-MAILED
  • 25 Mar 2026 — PETITION TO REVIVE-GRANTED
  • 25 Mar 2026 — TEAS PETITION TO REVIVE RECEIVED
  • 24 Mar 2026 — CORRECTED NOA E-MAILED
  • 24 Mar 2026 — DIVISIONAL PROCESSING COMPLETE
  • 03 Jul 2025 — DIVISIONAL REQUEST RECEIVED
  • 03 Jul 2025 — TEAS REQUEST TO DIVIDE RECEIVED
  • 12 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 17 Nov 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
  • 22 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 25 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

View this trademark record on Marksy